A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

ClinicalTrials.gov ID: NCT02018510

Public ClinicalTrials.gov record NCT02018510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 19, 2026, 2:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers

Study identification

NCT ID: NCT02018510
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Rockefeller University; Other
Enrollment: 49 participants

Conditions and interventions

Conditions

Interventions

1 mg/kg, single dose IV administration of 3BNC117 Biological
3 mg/kg, single dose IV administration of 3BNC117 Biological
10 mg/kg, single dose IV administration of 3BNC117 Biological
30 mg/kg, single dose IV administration of 3BNC117 Biological
10 mg/kg, two doses IV of 3BNC117 Biological
30 mg/kg, two doses IV of 3BNC117 Biological

Biological

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2013
Primary completion: Dec 31, 2015
Completion: Dec 31, 2015
Last update posted: Dec 25, 2016

2014 – 2016

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
The Rockefeller University	New York	New York	10065	—
Weill Cornell Medical Center	New York	New York	10065	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02018510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 25, 2016 · Synced Jul 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02018510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →